Actos Bladder Cancer Lawsuits
Patients who took Actos, ActoPlus Met, ActoPlus Met XR, or Duetact and were diagnosed with bladder cancer may have legal recourse. According to a FDA safety announcement concerning Actos and bladder cancer, patients taking pioglitazone, an ingredient found in these diabetes drugs, for more than a year may have an increased risk of developing cancerous tumors of the bladder. It has been alleged that drug maker Takeda Pharmaceutical withheld information about the Actos bladder cancer risk and failed to provide adequate warnings with its diabetes drug.

If you were diagnosed with bladder cancer after taking Actos, ActoPlus Met, ActoPlus Met XR, or Duetact, you may be entitled to financial compensation in light of these allegations. To find out if you are eligible, please complete our free, no obligation case review form today.

Shocking facts about the common diabetes drug Actos:
Actos Bladder Cancer Link
On June 15, 2011, the FDA released a safety announcement concerning Actos and bladder cancer. The agency released the Actos bladder cancer warning following a review of data from a five-year analysis of an ongoing study of the drug by the manufacturer, Takeda Pharmaceuticals. While there was no overall increased risk of Actos bladder cancer among users, patients with the longest exposure to pioglitazone had a greater chance of developing the disease, according to the results. Specifically, the study revealed that patients taking the drug for more than a year had a 40% higher risk of developing Actos bladder cancer.

The maker of Actos, Takeda, added a label to the drug warning of the cancer risk in August 2011. By then, Actos had already been on the market for more than 10 years and had been taken by many diabetics. The health and safety of these innocent people were put at risk.

In April 2014, federal jury found that Takeda Pharmaceuticals and Eli Lilly & Co. marketed Actos despite knowing about the risk of cancer it carries. They ordered the companies to pay a combined $10.475 billion in punitive and compensatory damages to an Actos victim, making it among the largest civil trial verdicts in history.

Takeda is facing thousands of lawsuits from people and families who have suffered due to Actos. Nearly 3,000 of these cases have been combined into what is known as a multi-district litigation in a Louisiana federal court and are awaiting trial.

You need to act quickly if you’ve also been harmed.

In light of the link between Actos and bladder cancer, the FDA has advised that pioglitazone should not be prescribed to individuals who have bladder cancer, and should be used with caution in patients with a history of the disease. The agency also advised users to be on alert for signs which may possibly indicate Actos bladder cancer, such as:

•  Blood in urine
•  Back or lower abdominal pain
•  Urgent need to urinate
•  Pain during urination

Due to the possible Actos bladder cancer link, the agency also announced that the risk will be reflected in the drug's label and patient medication guide.

Actos Bladder Cancer Lawsuits
Potentially, Actos, ActoPlus Met, ActoPlus Met XR, or Duetact users who were diagnosed with bladder cancer may be able to take legal action if the manufacturer failed to properly warn doctors and patients about the possible Actos bladder cancer risk. If you have been diagnosed with bladder cancer after taking one of these drugs, fill out our contact review form today to contact our Actos bladder cancer lawyers to find out if you can file a claim seeking compensation for medical bills, pain and suffering and other damages.

Lawsuits filed by people injured by Actos list a number of counts against Takeda and Eli Lilly, including failure to warn about side effects and willfully concealing the safety concerns with the drug.

•  Failed to warn the public and health care providers that taking Actos for longer than 12 months may increase the risk of bladder cancer
•  Manufactured a defective product
•  Failed to properly test Actos
•  Concealed testing and research data from the public
•  Provided misleading data to the public
•  Manufactured an unsafe product
•  Knew the dangers of the product, but sold it anyway to maximize profits
•  Breached warranty by selling a drug that was not fit for use

15,500+ Bladder Cancer Deaths Every Year
Bladder cancer will claim the lives of more than 15,500 Americans in 2014, according to the American Cancer Society, and it will be diagnosed in nearly 75,000 Americans this year. The cancer is much more common in men than women.

Symptoms of bladder cancer may include:

•  Abdominal pain
•  Blood in urine
•  Painful and/or frequent urination
•  Fatigue
•  Weight loss

Like other cancers, early detection is vital to increasing the odds of successfully fighting bladder cancer.

The U.S. has not joined the countries that have banned the sale of Actos to protect diabetics. However, the watchdog publication Consumer Reports has urged Americans to avoid Actos at all costs due to its dangers.

Contact Us Today
There is a time limit for filing Actos bladder cancer lawsuits. If you or someone you care about was stricken with bladder cancer after taking Actos, you should contact Hummer Law Offices by calling 727-397-9198 or filling out the form on this page. In a free, no-obligation consultation, one of our attorneys will tell you how we may be able to help you seek compensation for what has happened.
According to the Food and Drug Administration, people who take Actos for 1 year are 40% more likely to be diagnosed with bladder cancer
Diabetics who took Actos were 22% more like to develop bladder cancer than those taking other diabetes medications
A 2014 study in the British Journal of Clinical Pharmacology found a “clinically significant” increased occurrence of bladder cancer in patients taking Actos
France, Germany and India have banned Actos due to its dangers

Judges: Actos Manufacturer Destroyed Documents

MAY 2014: Judges in trials in Nevada and Louisiana told jurors that Takeda Pharmaceuticals, the maker of Actos, destroyed documents that may have supported the claims of Actos victims, the Las Vegas Review-Journal reported.
727-397-9198 9am-5pm / Mon.-Thu.